Carson Wealth (CWM LLC)
LGND icon

Carson Wealth (CWM LLC)’s Ligand Pharmaceuticals LGND Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.7K Buy
379
+37
+11% +$7.32K ﹤0.01% 3492
2025
Q4 		$65K Buy
342
+9
+3% +$1.73K ﹤0.01% 3410
2025
Q3 		$59K Buy
333
+39
+13% +$5.8K ﹤0.01% 3393
2025
Q2 		$33K Buy
294
+13
+5% +$1.39K ﹤0.01% 3584
2025
Q1 		$30K Buy
281
+52
+23% +$5.88K ﹤0.01% 3383
2024
Q4 		$25K Buy
229
+26
+13% +$2.94K ﹤0.01% 3291
2024
Q3 		$20K Buy
203
+7
+4% +$705 ﹤0.01% 3354
2024
Q2 		$17K Sell
196
-98
-33% -$7.8K ﹤0.01% 3222
2024
Q1 		$21K Sell
294
-101
-26% -$7.45K ﹤0.01% 2876
2023
Q4 		$28K Buy
395
+4
+1% +$236 ﹤0.01% 2561
2023
Q3 		$23K Buy
391
+201
+106% +$13.2K ﹤0.01% 2603
2023
Q2 		$14K Buy
190
+7
+4% +$525 ﹤0.01% 2874
2023
Q1 		$13K Buy
183
+7
+4% +$498 ﹤0.01% 2794
2022
Q4 		$12K Sell
176
-79
-31% -$5.14K ﹤0.01% 2701
2022
Q3 		$14K Hold
255
– – ﹤0.01% 2474
2022
Q2 		$14K Buy
255
+95
+59% +$5.39K ﹤0.01% 2372
2022
Q1 		$11K Sell
160
-53
-25% -$3.85K ﹤0.01% 2423
2021
Q4 		$21K Buy
+213
New +$19.7K ﹤0.01% 1969
2019
Q1 		– Sell
-3
Closed – – 3141
2018
Q4 		$0 Hold
3
– – ﹤0.01% 2183
2018
Q3 		$1K Hold
3
– – ﹤0.01% 1694
2018
Q2 		$0 Hold
3
– – ﹤0.01% 1734
2018
Q1 		$0 Hold
3
– – ﹤0.01% 1483
2017
Q4 		$0 Hold
3
– – ﹤0.01% 1523
2017
Q3 		$0 Hold
3
– – ﹤0.01% 1522
2017
Q2 		$0 Hold
3
– – ﹤0.01% 1256
2017
Q1 		$0 Buy
+3
New +$197 ﹤0.01% 1248

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Carson Wealth (CWM LLC)'s LGND Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Ligand Pharmaceuticals (LGND) stake by 11% in Q1 2026, buying an estimated $7.32K and bringing the position to 379 shares worth $75.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3492.

Carson Wealth (CWM LLC) first reported a position in LGND in Q1 2017 and has held it in 26 quarters since. 358 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Carson Wealth (CWM LLC) held 379 shares of Ligand Pharmaceuticals worth $75.7K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 37 Ligand Pharmaceuticals shares in Q1 2026, an estimated $7.32K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3492 holding.
  • Carson Wealth (CWM LLC) first reported a position in Ligand Pharmaceuticals in Q1 2017 and has held it in 26 quarters since.
  • 358 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.